Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 7/2009

01-09-2009

Quality of life in Serbian patients with Parkinson’s disease

Auteurs: Ljubomir Žiropađa, Elka Stefanova, Aleksandra Potrebić, Vladimir S. Kostić

Gepubliceerd in: Quality of Life Research | Uitgave 7/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Background

The Parkinson’s Disease Questionnaire (PDQ-39) is a well-validated British scale for the assessment of health-related quality of life (QoL) in Parkinson’s disease (PD).

Objective

To validate the Serbian version of the PDQ-39, while also providing additional information on the characteristics of this instrument.

Patient and methods

A total of 102 Serbian PD patients were asked to complete the PDQ-39, a disease-specific QoL questionnaire, as well as the generic, health status questionnaire (SF-36-version 1), and the 21-item Beck Depression Inventory. Neurological examination included the Hoehn and Yahr staging, Unified Parkinson’s disease rating scale (UPDRS)-part III, Schwab and England scale, and the Mini-Mental State Examination.

Results

Internal consistency analysis yielded a Cronbach’s α of 0.83. Cronbach’s α was above 0.70 for seven out of eight subscales (range from 0.73 to 0.91). A hierarchical structure of the PDQ-39 was revealed, with one global higher-order factor and two lower-order factors. The strongest predictor of the QoL in PD was the presence of depression, while motor disability (UPDRS-part III score) additionally contributed to poor QoL. Cognitive impairment has not been correlated with poor QoL. Also, QoL measures were not different between young- (≤50 years) and older-onset PD patients.

Conclusions

The PDQ-39 is a reliable and valid instrument for the assessment of QoL in Serbian PD patients.
vorige artikel Quality of life from the perspective of adolescents with cerebral palsy: “I just think I’m a normal kid, I just happen to have a disability”
volgende artikel Psychosocial adaptation status and health-related quality of life among older Chinese adults with visual disorders
Literatuur
1.
Peto, V., Jenkinson, C., Fitzpatrick, R., & Greenhall, R. (1995). The development and validation of a short measure of functioning and well-being for individuals with Parkinson’s disease. Quality of Life Research, 4, 241–248.PubMedCrossRef
2.
Martinez-Martin, P. (1998). An introduction to the concept of “quality of life in Parkinson’s disease”. Journal of Neurology, 245(Suppl 1), S2–S6.PubMedCrossRef
3.
Kuopio, A. M., Marttila, R. J., Helenius, H., Toivonen, M., & Rinne, U. K. (2000). The quality of life in Parkinson’s disease. Movement Disorders, 15, 216–223.PubMedCrossRef
4.
Schrage, A., Selai, C., Jahanshahi, M., & Quinn, N. P. (2000). The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 69, 67–73.CrossRef
5.
Diamond, A., & Jankovic, J. (2005). The effect of deep brain stimulation on quality of life in movement disorders. Journal of Neurology, Neurosurgery and Psychiatry, 76, 1188–1193.CrossRef
6.
Chaudhuri, K. R., Yates, L., & Martinez-Martin, P. (2005). The non-motor symptom complex of Parkinson’s disease: A comprehensive assessment is essential. Current Neurology and Neuroscience Reports, 5, 275–283.PubMedCrossRef
7.
Visser, M., van Rooden, S. M., Verbaan, D., Marinus, J., Stiggelbout, A. M., & van Hilten, J. J. (2008). A comprehensive model of health-related quality of life in Parkinson’s disease. Journal of Neurology, 255(10), 1580–1587.PubMedCrossRef
8.
Karlsen, K. H., Larsen, J. P., Tandberg, E., & Maeland, J. G. (1999). Influence of clinical and demographic variables on quality of life in patients with Parkinson’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 66, 431–435.CrossRef
9.
Schrage, A. (2006). Quality of life and depression in Parkinson’s disease. Journal of the Neurological Sciences, 248, 151–157.CrossRef
10.
Martinez-Martin, P., & Payo, F. B. (1998). Quality of life in Parkinson’s disease: Validation study of the PDQ-39 Spanish version. Journal of Neurology, 245(Suppl 1), S34–S38.PubMedCrossRef
11.
Bushnell, D. M., & Martin, M. L. (1999). Quality of life and Parkinson’s disease: Translation and validation of the US Parkinson’s disease Questionnaire (PDQ-39). Quality of Life Research, 8, 345–350.PubMedCrossRef
12.
Katsarou, Z., Bostantjopulou, S., Peto, V., Alevriadou, A., & Kiosseoglou, G. (2001). Quality of life in Parkinson’s disease: Greek translation and validation of the Parkinson’s disease Questionnaire (PDQ-39). Quality of Life Research, 10, 159–163.PubMedCrossRef
13.
Ma, H. I., Hwang, W. J., & Chen-Sea, M. J. (2005). Reliability and validity testing of a Chinese-translated version of the 39-item Parkinson’s disease Questionnaire (PDQ-39). Quality of Life Research, 14, 565–569.PubMedCrossRef
14.
Klepac, N., Pikija, S., Kraljić, T., et al. (2007). Association of rural life setting and poorer quality of life in Parkinson’s disease patients: A cross-sectional study in Croatia. European Journal of Neurology, 14, 194–198.PubMedCrossRef
15.
Krikmann, U., Taba, P., Lai, T., & Asserl, T. (2008). Validation of an Estonian version of the Parkinson’s disease Questionnaire (PDQ-39). Health and Quality of Life Outcomes, 6, 23.PubMedCrossRef
16.
Hughes, A. J., Daniel, S. E., Kliford, I., & Lees, A. J. (1992). Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinicopathological study of 100 cases. Journal of Neurology, Neurosurgery and Psychiatry, 55, 181–184.CrossRef
17.
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198.PubMedCrossRef
18.
Fahn, S., & Elton, R. L. (1987). Unified Parkinson′s disease rating scale. In S. Fahn, C. D. Marsden, M. Goldstein, & D. B. Calne (Eds.), Recent developments in Parkinson′s disease II (pp. 153–163). New York: MacMillan.
19.
Hoehn, M., & Yahr, M. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17, 427–442.PubMed
20.
Schwab, R. S., & England, A. C. (1969). Projection technique for evaluating surgery in Parkinson’s disease. In F. J. Gillingham & I. M. L. Donaldson (Eds.), Third symposium on Parkinson’s disease (pp. 152–157). Edinburgh: Livingstone.
21.
Beck, A. T., Ward, C. H., Mendelson, M., Mock, L., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.PubMed
22.
Jenkinson, C., Fitzpatrick, R., & Peto, V. (1998). The Parkinson’s Disease Questionnaire. Use manual for the PDQ-39, PDQ-8 and PDQ Summary Index. Oxford: Health Services Research Unit.
23.
Jenkinson, C., Wright, L., & Coulter, A. (1993). Quality of life measurement in health care: A review of measures and population norms for the UK SF-36. Oxford: Health Services Research Unit.
24.
STATISTICA (data analysis software system), version 7. (2006). Tulsa: StatSoft, Inc.
25.
Lance, C. E., & Vandenberg, R. J. (2009). Statistical and methodological myths and urban legends: Received doctrine, verity, and fable in organizational and social research. New York: Routledge.
26.
Schmid, J., & Leiman, J. (1957). The development of hierarchical factor solutions. Psychometrica, 22, 53–61.CrossRef
27.
Hagell, P., Törnqvist, A. L., & Hobart, J. (2008). Testing the SF-36 in Parkinson’s disease: Implications for reporting rating scale data. Journal of Neurology, 255, 246–254.PubMedCrossRef
28.
Auquier, P., Sapin, C., Ziegler, M., et al. (2002). Validation en langue française d’un questionnaire de qualité de vie dans la maladie de Parkinson: Le Parkinson’s Disease Questionnaire-PDQ-39. Revue Neurologique, 158(4), 1–50.
29.
Hagell, P., & Nygren, C. (2007). The 39-item Parkinson’s disease Questionnaire (PDQ-39) revisited: Implications for evidence-based medicine. Journal of Neurology, Neurosurgery and Psychiatry, 78, 1191–1198.CrossRef
30.
Flanagan, J. C. (1982). Measurement of the quality of life: Current state of the art. Archives of Physical Medicine and Rehabilitation, 63, 56–59.PubMed
31.
Burckhardt, C. S., Anderson, K. L., Archenholtz, B., & Hägg, O. (2003). The Flanagan quality of life scale: Evidence of construct validity. Health and Quality of Life Outcomes, 1, 59.PubMedCrossRef
32.
Global Parkinson’s Disease Survey (GPDS) Steering Committee. (2001). Factors impacting on quality of life in Parkinson’s disease: Results from an international survey. Movement Disorders, 17, 60–67.CrossRef
33.
Marinus, J., Visser, M., Jenkinson, C., & Stiggelbout, A. M. (2008). Evaluation of the Dutch version of the Parkinson’s disease Questionnaire-39. Parkinsonism & Related Disorders, 4, 24–27.CrossRef
34.
Aronson, E., Wilson, T. D., & Akert, R. M. (2007). Social psychology (6th ed.). Englewood Cliffs, NJ: Prentice Hall.
35.
Forsaa, E. B., Larsen, J. P., Wentzel-Larsen, T., et al. (2008). Predictors and course of health-related quality of life in Parkinson’s disease. Movement Disorders, 23, 1420–1427.PubMedCrossRef
36.
Muslimovic, D., Post, B., Speelman, J. D., Schmand, B., & de Haan, R. J. (2008). Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology, 70(23), 2241–2247.PubMedCrossRef
37.
Schrag, A., Hovris, A., Morley, D., et al. (2003). Young- versus older-onset Parkinson’s disease: Impact of disease and psychosocial consequences. Movement Disorders, 18, 1250–1256.PubMedCrossRef
Metagegevens
Titel
Quality of life in Serbian patients with Parkinson’s disease
Auteurs
Ljubomir Žiropađa
Elka Stefanova
Aleksandra Potrebić
Vladimir S. Kostić
Publicatiedatum
01-09-2009
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 7/2009
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-009-9500-4

Andere artikelen Uitgave 7/2009

Quality of Life Research 7/2009 Naar de uitgave

OriginalPaper

Psychometric validation of two patient-reported outcome measures to assess symptom severity and changes in symptoms in hereditary angioedema

OriginalPaper

Readability estimates for commonly used health-related quality of life surveys

OriginalPaper

Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items

OriginalPaper

Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial

OriginalPaper

The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV/AIDS

OriginalPaper

Development of a battery of instruments for detailed measurement of health status in patients with COPD in routine care: the Nijmegen Clinical Screening Instrument